🔥🐔 BizChicken 🐔🔥
Learn About the Corporations Around You
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
Vor Biopharma Inc.
Market Cap: Lowest
Employees: Low
VOR33
Vor Biopharma, Inc. is a clinical-stage company focused on developing engineered hematopoietic stem cell (e HSC) therapies for cancer patients, with a leading product, VOR33, in phase 1/2 trials for AML and other hematological malignancies.
Website
About | Vision/Values | About | Leadership | Directors | About | About | Contact | Contact | News | Careers | About | About | About
Symbol: VOR
Recent Price: $1.19
Industry: Biotechnology
CEO: Dr. Robert Ang M.B.A., M.D., MBBS
Sector: Healthcare
Employees: 168
Address: 100 Cambridgepark Drive, Cambridge, MA 02140
Phone: 617 655 6580
Leadership
- Robert Ang, MBBS, MBA, President and Chief Executive Officer
- Eyal Attar, MD, Chief Medical Officer
- Tirtha Chakraborty, PhD, Chief Scientific Officer
- Han Choi, MD, LLM, Chief Financial Officer
- John King, MBA, Chief Commercial Officer and Head of Business Development
- Tania Philipp, Chief People Officer
- David Phillips, MBA, Senior Vice President, Head of Quality
- Samir Vattompadam, MS, Senior Vice President, Portfolio Strategy and Program Management
- Daniella Beckman, Board of Directors
- David Lubner, Board of Directors
- Bill Lundberg, MD, Board of Directors
- Fouad Namouni, MD, Board Of Directors
- Matthew R. Patterson, Chairman, Board of Directors
- Josh Resnick, MD, Board of Directors
Last updated: 2024-12-31